Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2.

× No keyword cloud information.

34 in total

1. Autologous tumor cell vaccination combined with adoptive cellular immunotherapy in patients with grade III/IV astrocytoma.

Authors: F P Holladay; T Heitz-Turner; W L Bayer; G W Wood
Journal: J Neurooncol Date: 1996-02 Impact factor: 4.130

Review 2. IL-2: the first effective immunotherapy for human cancer.

Authors: Steven A Rosenberg
Journal: J Immunol Date: 2014-06-15 Impact factor: 5.422

3. In vivo and in vitro synergistic antitumor effect of interleukin-2-cultured tumor-bearer spleen cells and immune fresh spleen cells.

Authors: N Kan; T Okino; M Nakanishi; K Satoh; K Ohgaki; T Tobe
Journal: Cancer Immunol Immunother Date: 1989 Impact factor: 6.968

4. A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma.

Authors: A Lindemann; K Höffken; R E Schmidt; V Diehl; O Kloke; H Gamm; J Hayungs; W Oster; M Böhm; J E Kolitz
Journal: Cancer Immunol Immunother Date: 1989 Impact factor: 6.968

5. Amplification of altered self-reactive cytolytic T lymphocyte responses by cloned, allospecific human Th cells.

Authors: S M Friedman; A Green; C Russo; D N Posnett; D Diffley; M K Crow
Journal: J Clin Invest Date: 1988-11 Impact factor: 14.808

6. Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

Authors: M A Cheever; P D Greenberg; A Fefer; S Gillis
Journal: J Exp Med Date: 1982-04-01 Impact factor: 14.307

7. Protection against syngeneic lymphoma by a long-lived cytotoxic T-cell clone.

Authors: M O Dailey; E Pillemer; I L Weissman
Journal: Proc Natl Acad Sci U S A Date: 1982-09 Impact factor: 11.205

8. Lethal effect of the intravenous injection of H-2 alloantigen activated T cells.

Authors: L Andrus; K Atkinson; K J Lafferty
Journal: Clin Exp Immunol Date: 1982-12 Impact factor: 4.330

9. Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF).

Authors: E Kedar; B L Ikejiri; E Gorelik; R B Herbermann
Journal: Cancer Immunol Immunother Date: 1982 Impact factor: 6.968

10. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.

Authors: A R Pachner; F S Kantor
Journal: Clin Exp Immunol Date: 1984-06 Impact factor: 4.330